SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-24-000794
Filing Date
2024-03-04
Accepted
2024-03-04 08:30:43
Documents
17
Period of Report
2024-03-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk2431079.htm   iXBRL 8-K 32856
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 11654
7 image0.jpg GRAPHIC 4528
  Complete submission text file 0001178913-24-000794.txt   235964

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA entx-20240304.xsd EX-101.SCH 4677
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE entx-20240304_def.xml EX-101.DEF 17920
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE entx-20240304_lab.xml EX-101.LAB 27966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE entx-20240304_pre.xml EX-101.PRE 20105
19 EXTRACTED XBRL INSTANCE DOCUMENT zk2431079_htm.xml XML 6720
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 24712944
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)